BMAL1 and osteosarcoma: Using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc (Oshima et al, 2015), we screened over 1,000 molecules from an FDA‐approved drug library and the IDC to identify new circadian clock modulators.